Pfs Partners, LLC Royalty Pharma PLC Transaction History

Pfs Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	BUY	$26.21 - $29.22 $26 - $29	1 Added 0.49%	206 $5.8 Million
Q3 2023 Nov 30, 2023	BUY	$26.26 - $31.38 $52 - $62	2 Added 0.99%	205 $5.56 Million
Q2 2023 Nov 30, 2023	BUY	$29.6 - $36.56 $29 - $36	1 Added 0.5%	203 $6.25 Million
Q1 2023 Nov 30, 2023	BUY	$32.77 - $39.4 $32 - $39	1 Added 0.5%	202 $7.28 Million
Q4 2022 Nov 30, 2023	BUY	$39.17 - $44.04 $39 - $44	1 Added 0.5%	201 $7.94 Million
Q3 2022 Nov 30, 2023	BUY	$39.88 - $44.65 $7,976 - $8,930	200 New	200 $8.04 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Pfs Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pfs Partners, LLC with notifications on news.